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Abstract
Myopia is the most prevalent refractive error in the world and its incidence is 
increasing. Together with conservative methods of treatment, various surgical 
methods have been proposed. Corneal refractive surgery is probably the most 
accepted one. Laser in situ keratomileusis (LASIK), photorefractive keratectomy 
(PRK), and small incision lenticule extraction (SMILE) are suitable for treatment of 
myopia up to −8.00 D in the younger age group. For patients not suitable for corneal 
refractive surgery, lens-based procedures are available. Phakic intraocular lenses are 
suitable for patients younger than 45 years of age with high myopia or some other 
contraindications for corneal refractive surgery. For older patients, refractive lens 
exchange (RLE) with implantation of multifocal or monofocal intraocular lenses is 
gaining popularity.
Keywords: myopia, LASIK, PRK, SMILE, phakic intraocular lenses,  
refractive lens exchange
1. Introduction
Myopia is a common refractive error in the population. It is defined as an optical 
aberration in which parallel light rays from a distant image are getting focused on 
a point anterior to the retina. Hereditary and environmental factors both play an 
important role in the development of myopia. Myopia typically appears between the 
age of 6 and 12, and the mean rate of progression is considered to be approximately 
0.50 D per year, based on studies of mostly Caucasian children. One of the studies 
showed that progression of myopia can vary by ethnicity, as well as by age of the 
child. For instance, in ethnic Chinese children, the progression rate is higher [1].
A recent report in Nature, entitled “The Myopia Boom,” demonstrated, and it is 
now widely accepted, that there is an epidemic of myopia in the developed countries 
of East and Southeast Asia, paralleled by an epidemic of high myopia [2]. Recent 
meta-analyses have suggested that close to half of the world’s population may be myo-
pic by 2050, with as much as 10% highly myopic [3]. Correction of refractive error 
can be achieved conservatively with glasses or contact lenses which is the treatment of 
choice in the childhood. However, despite the long-standing use of glasses and contact 
lenses, there are some disadvantages in both forms of optical correction. Increased 
light scatter, image magnification/minification, discomfort, and inconvenience are 
some of the issues with glasses, while contact lenses may irritate the ocular surface 
with increased risk of corneal scratches and infections. After the age of 21, vari-
ous surgical treatments can be considered. The best surgical option depends on the 
amount of refractive error and the patient’s cornea, lens, and age. Available options 
include various laser vision corrections which are aimed on the cornea, implantation 
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of phakic intraocular lenses (pIOLs), and refractive lens exchange (RLE) with 
implantation of multifocal and monofocal intraocular lenses (IOLs). It is important 
to perform a detailed examination of each patient and assess their needs, wishes, and 
expectations. Doctors need to explain in as much detail as possible what the expected 
results and risk would be with for the selected surgical method.
2. Corneal refractive surgery
Procedures which involve altering the shape of the cornea with excimer laser 
are collectively referred to as keratorefractive surgery, refractive keratoplasty, laser 
vision correction, or refractive corneal surgery.
2.1 Photorefractive keratectomy
Photorefractive keratectomy (PRK) was the first excimer laser technique for 
the treatment of refractive errors. Seiler performed the first corneal ablation in a 
live patient in 1985, and McDonald treated the first human sighted eye in 1985 after 
extensive preclinical investigation [4]. The PRK procedure involves removal of 
the central corneal epithelium, most commonly performed mechanically (brush, 
crescent knife, or alcohol) or with excimer laser when it is referred as transepithelial 
PRK (T-PRK). The denuded anterior stroma is then reshaped by the excimer laser, 
with either central corneal flattening, steepening, or a torical pattern when treating 
myopia, hyperopia, or astigmatism, respectively. Due to significant postoperative 
pain, relatively slow visual recovery, epithelial defects due to irregular healing, and 
haze development, especially when treating high myopia [5, 6], different techniques 
of epithelial removal were introduced over time to solve these complications [7]. 
Recently the role of surface ablations has been reevaluated due to raised issues of 
potential flap complications, risk of iatrogenic corneal ectasia, and inability to treat 
thin corneas with laser in situ keratomileusis (LASIK) [8]. With surface ablation 
techniques, there is no flap involved, and more cornea tissue is preserved, and 
by some it is still considered the overall safest procedure for treatment of low to 
moderate myopia [9]. It is performed, especially in corneas with superficial scar-
ring, epithelial dystrophies, or recurrent erosions, in thin corneas, after penetrating 
keratoplasty and for keratorefractive retreatments. The introduction of mitomycin 
C and modern surface ablation techniques has also increased the range of treatment 
and lowered the risk of haze and regression after PRK [10]. Therefore today surface 
ablation includes several sub-techniques such as epithelial LASIK (epi-LASIK), 
laser-assisted subepithelial keratectomy (LASEK), and T-PRK [11].
2.2 Laser in situ keratomileusis
The term LASIK was first used in 1990 by Pallikaris [4]. The procedure is per-
formed in two steps. The first step involves the formation of a front corneal flap and 
the lifting of the flap for the purpose of exposing the corneal stroma. The hinged flap 
consists of the corneal epithelium, the Bowman membrane, and superficial stroma. 
The second step is the application of the excimer laser on the stromal bed. Once the 
ablation with the excimer laser is finished, the flap is returned into its original position.
LASIK has now become the most common elective surgical procedure in the 
world, presumably because it is almost painless with fast visual recovery, as compared 
to PRK [4]. Nowadays, there are two techniques available for the formation of the 
flap—mechanical microkeratomes and femtosecond lasers. The use of femtosecond 
laser-assisted laser in situ keratomileusis (FsLASIK) offers greater precision in flap 
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creation leading to better morphological stability of the flap compared to earlier bladed 
microkeratome keratomileusis. However, changes in the biomechanical strength of 
the cornea, induction of higher-order aberrations, and flap-related complications can 
still occur [12]. LASIK reduces the tensile strength of the stroma by about 35% when 
the ablation takes place between 10 and 30% of the stromal depth [13]. Regarding the 
available data, and our experience, there is no significant difference in shorter-term 
refractive stability and induction of high-order aberrations between T-PRK and LASIK 
(Figures 1 and 2 and Table 1). However, when higher refractive errors are treated, 
surface ablations pose more risk for haze development and regression [14].
2.3 Small incision lenticule extraction
The femtosecond laser corneal procedure known as small incision lenticule 
extraction (SMILE) was originally described by Sekundo et al. and became clinically 
Figure 1. 
Comparison of change in spherical correction over time between T-PRK and LASIK.
Figure 2. 
Comparison of change in astigmatism correction over time between T-PRK and LASIK.
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Figure 3. 
Polar diagram showing target and surgically induced astigmatic values for the SMILE group. The concentric 
semicircles reduce in 0.50 D steps from −2.00 DC (outermost semicircle) toward zero (central point) in 0.50 DC 
steps. From right to left, the 0 to 90 to 180° axes are shown in 30° steps. The target and surgically induced 
astigmatism data points are shown as empty circles and filled dots, respectively.
available in 2011 [15]. The procedure does not require the creation of a flap: two pre-
cise intrastromal planar sections are created using a single femtosecond laser to form 
an intrastromal lenticule. The intrastromal lenticule is dissected from the pocket, 
grasped with a forceps, and manually extracted through a small incision. The incision 
is placed at the superior temporal/nasal quadrant, usually angled at 70°, and 2–5 mm 
in length. The removal of the intrastromal lenticule alters the shape of the cornea, 
thereby correcting myopia and astigmatism. Since Bowman’s layer remains intact, the 
procedure offers greater biomechanical stability, especially in the treatment of higher 
levels of myopia [15]. The flapless property of SMILE obviates the risks associated 
with LASIK including adverse events at flap creation and dislocation [16].
The tensile strength of the cornea may reduce by 55% after a SMILE procedure 
when the lenticule is formed and extracted from the anterior half of the stroma. Loss of 
tensile strength is less profound when the lenticule is extracted from deeper regions of 
the stroma. Thus, the exact change in the biomechanical properties of the cornea will 
depend on the amount of ablation and the location where the lenticule is formed [13].
Regarding the available data, and our experience, LASIK and SMILE are com-
parable procedures in terms of visual quality and reduction of myopia; however, in 
treating astigmatism LASIK still offers better precision (Figures 3 and 4).
2.4 Indications and preoperative preparation for refractive surgery
A detailed review of the patient’s condition before surgery and informing the 
patient about the results, benefits, and disadvantages of the procedure are the most 
important steps for a successful outcome of refractive surgery [17].
Table 1. 
Comparison of change in high-order aberrations over time between T-PRK and LASIK.
5Surgical Correction of Myopia
DOI: http://dx.doi.org/10.5772/intechopen.85644
The examination should include detailed medical history (systemic status, 
medications intake, allergies, ocular status, information about previous ocular 
surgeries—especially in the case of refractive lens exchange—and information 
about contact lens wear) and reasons/motivations for refractive surgery to iden-
tify patients with unrealistic expectations [18, 19]. It is important for patients to 
understand that refractive surgery primarily serves to reduce spectacle dependence 
and contact lens use, and it is not meant to completely remove all optical aids in all 
situations, for an indefinite time period.
Patients should discontinue contact lens use before the examination (for soft 
contact lenses, at least a week prior to the examination, and for rigid gas permeable 
contact lenses, at least 2–3 weeks prior) since corneal topography and biometry 
measurement can be severely affected by the corneal changes induced by contact 
lens wear. In the case of corneal warpage syndrome (corneal irregularities caused by 
contact lenses), contact lenses should be discontinued for at least 4–6 weeks [20].
The preoperative evaluation must include monocular manifest refraction, 
cycloplegic refraction, uncorrected distance visual acuity (UDVA), corrected 
distance visual acuity (CDVA), pupillometry, tonometry, anterior chamber depth 
(ACD) measurement, corneal topography/tomography, pachymetry, aberrometry, 
tear film quality and quantity, determining the dominant eye, ocular motility, and a 
fundus examination [18, 21]. Cycloplegic refraction is recommended to exclude the 
accommodation effect, while in patients in/or close to presbyopia age near visual 
acuity should be checked also. It is mandatory to check the patient’s refractive sta-
bility during the time, which can most often be obtained by inspecting the patient’s 
eyeglasses or by reviewing the previous ophthalmological documentation [21].
Contraindications for refractive surgery may relate to systemic or ocular disor-
ders. Absolute systemic contraindications are poorly controlled systemic immune 
diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus, polyarteritis 
nodosa), as well as poorly controlled diabetes and AIDS. Such patients have a higher 
risk of complications associated with prolonged inflammation or corneal healing 
after refractive surgery [18, 22–24]. Surgical procedures are not recommended dur-
ing pregnancy and lactation [25].
Ocular absolute contraindications are considered to be poorly controlled or 
untreated eye inflammation (blepharitis, dry eye syndrome, atopy/allergy), 
poorly controlled glaucoma, clinically significant lens opacities, Stevens-Johnson 
syndrome, ocular pemphigoid, and chemical burns of the eye surface [26, 27]. 
Instability of refraction (i.e., a change greater than 0.50 D within a year) is 
Figure 4. 
Polar diagram showing target and surgically induced astigmatic values for the FsLASIK group. The concentric 
semicircles reduce in 0.50 D steps from −2.00 DC (outermost semicircle) toward zero (central point) in 0.50 DC 
steps. From right to left, the 0 to 90 to 180° axes are shown in 30° steps. The target and surgically induced 
astigmatism data points are shown as empty circles and filled dots, respectively.
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considered as an absolute contraindication, as well as insufficient corneal thickness 
or corneal irregularities suspicious for keratoconus [21, 26, 28, 29]. Precautions are 
also needed in patients with certain systemic therapies (isotretinoin, amiodarone, 
sumatriptan, colchicine) [23, 24, 30]. Caution is also required in functional monoc-
ular patients and in patients with well-controlled glaucoma. Other relative contra-
indications are history of uveitis, herpes simplex, and varicella zoster keratitis. In 
patients with epithelial basal membrane degeneration, LASIK is not recommended, 
but PRK is the procedure to consider [21, 31].
2.5 Limitations and complications of corneal refractive surgery
Complications of corneal refractive surgery are considered rare. They can be divided 
in intraoperative and postoperative complications (which can be early or delayed).
Regarding the intraoperative complications, they are mainly correlated with 
corneal flap creation or excimer laser ablation. During the era of microkeratome, 
flap-related complications were encountered more often and fell within 3%; with 
the introduction of femtosecond lasers, they were almost nullified; however, some 
complications specific to femtosecond lasers appeared [32].
Flap-related complications include free or partial flap creation, incomplete and 
irregular flap creation, thin and perforated flaps, and corneal perforation. Those 
complications were mostly related to corneal anatomy (flat <41.00 D or steep >46.00 
D corneas, small corneal diameter), inadequate suction, mechanical failure—a 
defect in the dissection blade or motor unit—and surgeon experience. Penetration 
into the anterior chamber is extremely rare and may occur during lamellar dissection 
or excimer laser photoablation usually on extremely thin corneas with old scars [33].
Femtosecond-related complications are closely correlated with cavitation 
bubbles and formation of the flap. They are presented in the form of confluent 
cavitation bubbles in the corneal lamellae or anterior chamber which can interfere 
with excimer laser systems and vertical gas breakthrough which is presented in the 
forms of incomplete buttonholes or difficulties in dissecting the flap due to tissue 
bridges [34]. Temporary hypersensitivity to light and rainbow glare are complica-
tions exclusively related to energy and pattern of femtosecond lasers characterized 
with normal visual acuity and photophobia without inflammation or light disper-
sion in low light conditions [35].
Laser-related complications include decentration of excimer laser ablation, 
irregular astigmatism, and formation of central islands. Those complications are 
clinically characterized by poor uncorrected and corrected distance visual acuity 
complaints of glare, “ghosting” around images and haloes, and refractive astigma-
tism in the axis of decentration [33].
Early postoperative complications include flap striae, diffuse lamellar keratitis, 
central toxic keratopathy, pressure-induced steroid keratitis, infectious keratitis, 
and epithelial ingrowth.
Flap striae are caused by misalignment of the flap; peripheral striae usually are 
asymptomatic; however, central location of the striae is associated with loss in cor-
rected distance visual acuity and night vision disturbances [33, 36].
Diffuse lamellar keratitis (Sands of Sahara syndrome) is a sterile inflammation 
probably caused by the introduction of toxins in the flap interface [37, 38]. It is 
graded in four stages, with stage one and two being mild and visually unthreaten-
ing, while stage four can lead to corneal melting and permanent changes [33, 39]. 
In comparison to diffuse lamellar keratitis, central toxic keratopathy is a rare 
noninflammatory central corneal opacification linked to enzymatic degradation of 
keratocytes with spontaneous resolution and mild central opacification which often 
causes refractory hyperopic shift [40].
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Pressure-induced stromal keratitis is also easily mistaken with diffuse lamel-
lar keratitis but is caused by postoperative steroid use which leads to increase in 
intraocular pressure and represents as cystoid lamellar edema [41].
Infectious keratitis after LASIK is extremely rare but can be quite serious since 
invading organisms are already implanted into the deep corneal stroma. The most 
often isolated organisms include Streptococcus pneumoniae, Staphylococcus aureus, 
Mycobacterium chelonae, and Nocardia asteroides [33, 42].
Epithelial ingrowth under the LASIK flap is reported to occur in merely 1–2% 
of patients and is caused by migration of epithelial cells under the flap. It is usually 
insignificant, but if epithelial cells continue to grow, it can cause flap distortion and 
melting causing visual disturbances [43].
Late postoperative complications include dry eye, night vision problems, corneal 
haze, regression of refractive error, and iatrogenic corneal ectasia.
Dry eye syndrome is caused by denervation and cutting of nerve fibers during 
the formation of the flap, removal of corneal tissue by excimer laser, and changes in 
the shape of the cornea. Dry eye syndrome is usually transient and symptoms fade 
away after healing period. It causes discomfort, fluctuation in vision quality, slower 
healing, and epithelial damage and may lead to regression of refractive error and 
reduced vision quality [44].
Symptoms of impaired visual quality are usually more expressed during the 
night due to physiological pupil dilatation. The main causes of nighttime issues 
are the increase in spherical aberrations at the centrally flatted cornea, decentered 
ablations, too small optical zones, newly emerging lens opacities, and induced 
astigmatism [45].
Corneal haze reduces corneal transparency at variable degrees and is more 
common after PRK and correction of high myopia (>−6.00 D). Besides the abla-
tion depth, it is correlated with an excessive ocular UV-B radiation, duration of the 
epithelial defect, postoperative steroid treatment, male sex, and certain population 
with brown iris [46].
Regression of refractive error is defined as return of part of the primary refrac-
tive error and is associated with increase in thickness and curvature of the cornea. 
Potential mechanisms include nuclear sclerosis, stromal synthesis (wound healing), 
compensatory epithelial hyperplasia, and iatrogenic keratectasia [47].
Postoperative ectasia is linked to biomechanical weakening of the cornea and is 
characterized with progressive corneal steepening, either centrally or inferiorly, result-
ing in severe progressive irregular astigmatism and decrease of both uncorrected and 
best-corrected visual acuity. The incidence of ectasia after LASIK has been estimated 
between 0.04 and 0.9% [48]. Risk factors include abnormal topographic findings, thin 
cornea, and high myopia together with young age at the time of surgery [49].
Intraoperative complications of SMILE procedure are usually not sight threaten-
ing, and the procedure usually can be continued [13, 15, 50]. The most common 
complications are incision or cap tears, suction loss, cap perforation, black spots, 
and opaque bubble layer which lead to cap lenticular adhesions and retained 
lenticule. Regarding the postoperative complications of SMILE procedure, they 
are similar to all laser refractive procedures and include epithelial ingrowth, dry 
eye, diffuse lamellar keratitis, corneal haze, irregular astigmatism, minor interface 
infiltrates, increased aberrations, and iatrogenic ectasia [50, 51].
3. Intraocular correction of myopia
Two basic intraocular procedures exist: phakic intraocular lens (pIOL) implanta-
tion and refractive lens exchange (RLE) with posterior chamber IOL implantation.
Intraocular Lens
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3.1 Phakic intraocular lenses
Phakic intraocular lenses (pIOL) provide a safe and effective alternative for 
young patients with moderate to high refractive errors who may not be suitable 
candidates for excimer laser procedures or who prefer a reversible form of vision 
correction with efficacy comparable to results of LASIK [52]. It has been established 
that attempted corrections of high myopia with excimer laser procedures induce 
more higher-order aberrations, affecting vision quality and creating problems 
such as glare, halos, and ghost imaging [53]. Additional advantages of intraocular 
procedures are a broader range of treatable ametropia, faster visual recovery, more 
stable refraction, and better visual quality. In addition, the pIOL implantation does 
not affect accommodation, and the procedure is reversible [52, 54].
Currently, there are two types of phakic intraocular lenses approved for cor-
recting refractive errors: anterior chamber—iris fixated—and posterior chamber. 
Verisyse and Veriflex lenses are iris-fixated intraocular lenses. More than 160,000 of 
these lenses have been safely implanted worldwide [55]. The Verisyse pIOL is made 
from rigid, ultraviolet-absorbing polymethyl methacrylate (PMMA). This lens 
requires a 5.5–6.5-mm incision, depending on the optic size of the lens, whereas the 
Veriflex pIOL requires a 3.2-mm incision. The Verisyse pIOL is available for myopia, 
hypermetropia, and astigmatism. For myopia, the pIOL is available in powers from 
−1.00 to −23.50 D in 0.50 D steps with two optic diameters of 5.0 or 6.0 mm. The 
Veriflex pIOL is a foldable implant with 6.0 mm flexible optic made of hydrophobic 
polysiloxane and features a PMMA haptic. It is available only for myopia in powers 
ranging from −2.00 to −14.50 D in 0.50 D steps.
The Visian Implantable Collamer Lens (ICL) is a posterior chamber phakic intra-
ocular lens resting in the ciliary sulcus. ICL is made from soft advanced collamer 
material and requires 3.2 mm incision. It is available for myopia, hypermetropia, 
and astigmatism. For myopia, the pIOL is available in powers from −0.50 to −18.00 
D in 0.50 D steps with four lens diameters (12.1, 12.6, 13.2, 13.6 mm) and optical 
zone up to 6.1 mm.
3.1.1  Preoperative examination and indications for phakic intraocular lens implantation
The preoperative evaluation of a patient for pIOL is the same as for any kind 
of refractive procedure. Inclusion criteria are more than 21 years of age, refractive 
stability (<0.50 D of change) for at least 1 year, ACD ≥ 3.0 mm measured from 
endothelium, endothelial cell count >2300 cells/mm2 (>2500 cell/mm2 if <40 years 
of age, > 2000 cells/mm2 if >40 years of age), irido-corneal angle ≥30° (at least 
grade II by gonioscopy examination), mesopic pupil size <6.00 mm, no anomaly of 
iris or pupil function, no evolving retinal pathology, absence of uveitis or any kind 
of ocular inflammation, and absence of glaucoma or any systemic immunological 
disorder [56, 57].
3.1.2 Intraocular lens power calculation and diameter selection
pIOL optic power is calculated with the software provided by the manufacturer. 
The calculation is based on the formula developed by van der Heijde [58]. The 
formula uses the patient’s refraction at the 12-mm spectacle plane or the vertex 
refraction, the corneal keratometry dioptric power at its apex, and central ACD [59]. 
For Verisyse and Veriflex lenses, only one lens diameter is available, while for the ICL 
overall diameter depends on the ciliary sulcus diameter and should provide perfect 
stability with no excess of compression forces to the sulcus and allow correct vaulting. 
The ICL’s diameter should be oversized 0.5–1.0 mm from the white-to-white (WTW) 
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measurements in myopic eyes and the same length or oversized 0.5 mm in hyperopic 
eyes. The internal diameter of the ciliary sulcus can be measured by ultrasound biom-
etry (UBM) or can be approximated by horizontal WTW measurement obtained 
manually using a caliper or automatically by topographic or biometric devices [60].
3.1.3 Limitations and possible complications of phakic intraocular lenses
The complications relating to pIOLs can, at times, be more disabling than those 
from keratorefractive surgery. Night vision problems, corneal decompensation, 
glaucoma, cataract formation, dyscoria, uveitis, and endophthalmitis are potential 
complications after pIOL implantation. Night vision problems such as glare, halos, 
and diplopia are related to decentration of the pIOL and/or an optic diameter that is 
too small relative to the pupil size [61].
Surgically induced astigmatism is an issue primarily correlated with rigid Verisyse 
lenses and incision diameter. However, some investigators reported that the resulting 
surgically induced astigmatism (SIA) was less than expected [62, 63]. However, when 
compared with the Veriflex pIOL and ICL, the SIA was significantly higher [64].
Implantation of a pIOL, whether iris fixated or positioned in the posterior cham-
ber, is associated with an accelerated decrease in endothelial cell density (ECD) 
[60]. Damage to the corneal endothelium may be due to the direct contact between 
pIOL and the inner surface of the cornea during implantation, from postoperative 
changes in pIOL position, or from subclinical inflammation, and direct toxicity to 
the endothelium. The magnitude of ECD loss after phakic intraocular lens implan-
tation surpasses the expected natural annual decrease of 0.6% as reported in a 1997 
benchmark study based on 42 adults [65]. Following implantation of an iris-claw 
phakic intraocular lens, the loss of ECD is highest during the first year varying 
between 0.75 and 7.2% [66]. Thereafter, the ECD loss continues without following 
an obvious pattern, to about 8.9% after 10 years. However, with an ICL the impact 
on the endothelium is claimed to be lower because the implant is placed in the 
posterior chamber further away from the endothelium itself. For the ICL the ECD 
loss is about 1.7% after 2 years [60] increasing to 6.2% after 8 years [54] and up to 
19.75% after 12 years [67].
In our experience after ICL implantation, there is a linear decrease in ECD over 
a 3-year period, without any signs of exponential EC loss or reaching a plateau or 
stable ECD during this time (Figure 5).
With modern pIOL designs, increased intraocular pressure (IOP) seems to be 
relatively uncommon after 3 months postoperatively and is typically thought to be 
related to corticosteroid response [68]. Posterior chamber pIOLs cause narrowing 
of anterior chamber angle due to its position in ciliary sulcus, and its sizing (too 
long lenses which cause excessive vaulting >750 μm) is closely correlated with 
possible angle-closure glaucoma, pupillary block glaucoma, or pigmentary disper-
sion glaucoma [69, 70]. Given the risk of pupillary block, peripheral iridectomy 
or iridotomy is carried out as a preventative measure in anterior pIOL procedures, 
while in newer models of ICL with aquaport, technology is not needed.
Pupil ovalization/iris retraction is mainly correlated with iris-fixated pIOL and 
can occur if fixation of the pIOL haptics is performed asymmetrically [61, 68, 71]. 
No progressive pupil ovalization has been reported.
Formation of cataract due to the iris-claw pIOL is unlikely because the pIOL 
is inserted over a miotic pupil without contact with the crystalline lens [61]. The 
incidence of cataract formation was 1.1% for the iris-fixated pIOL. The overall 
incidence of cataract formation for posterior chamber pIOLs was 9.60%, which is 
significantly higher in comparison to iris-fixated pIOLs [72]. With various genera-
tions of the ICL, appearance of cataract formation is different. The less vaulted 
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model V3 caused a higher incidence of cataract formation than the newer V4 and 
V5 models [73]. With the V4 model, the recently published FDA study showed an 
incidence of 2.1% anterior subcapsular opacities, which is the most common type 
of cataract after pIOL [59]. Possible reasons are operative trauma, continuous or 
intermittent contact of the posterior chamber pIOL with the crystalline lens, insuf-
ficient nutrition through anterior chamber flow between the posterior chamber 
pIOL and the crystalline lens, and chronic subclinical inflammation with disruption 
of the blood-aqueous barrier due to friction between the pIOL and posterior iris or 
the haptic on the ciliary sulcus [74–76].
The risk of uveitis is a concern given the proximity of pIOLs to the iris, but it 
does not seem to be a significant long-term complication with modern designs. With 
iris-fixated pIOLs, a difficulty with enclavation of the iris can lead to iris atrophy 
and decentration of the implant [52]. Retinal detachment seems to be uncommon 
and lower than in clear lens extraction cases [68, 77]. A few cases of endophthal-
mitis have been reported after pIOL implantation, but it seems less common after 
pIOL implantation and then after cataract surgery [78, 79].
3.2 Refractive lens exchange
Refractive lens exchange (RLE) is by definition used to indicate the replacement of 
the cataractous/clear crystalline lens with an intraocular lens (IOL) to achieve emme-
tropia/near emmetropia. The improved efficacy, predictability, and safety of modern-
day phacoemulsification have resulted in a resurgence of lens extraction as a modality 
for correction of high myopia. Increased numbers of RLE are being performed 
worldwide, especially in patients not suitable for LASIK or pIOL or with early lens 
changes in the presbyopia age group [80, 81]. Optics of the IOL confer better quality 
of vision as compared with LASIK, and this optical quality does not degrade with time 
except in the presence of a posterior capsular opacification. The refractive results are 
predictable and stable with a larger range of refractive correction possible than with 
either LASIK or pIOL. RLE addresses refractive error and cataract and with the use of 
modern multifocal IOLs results in a significant degree of spectacle independence for 
the patient. Visual recovery is faster, and it is more cost-effective, as the higher cost of 
pIOLs and future cataract surgery is eliminated. The principles of surgery are in the 
domain of most cataract/anterior segment surgeons [82].
Overall, patient satisfaction scores after implantation of multifocal IOLs are 
high. For example, using a 0–10 self-recording analogue scale, you can expect 
Figure 5. 
Mean endothelial cell density during the 3-year follow-up (28 eyes); ± SD error bars are included indicating the 
variance in the data.
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typical average satisfaction scores of 8.8 (Zeiss bifocal IOL, n = 48, range 2–10) and 
9.00 (Zeiss trifocal IOL, n = 52, range 4–10). On closer examination satisfaction 
scores are closely linked to post-op uncorrected distance and intermediate, visual 
acuity as demonstrated in Figure 6.
Advanced technology multifocal IOLs tend to be less forgiving with respect 
to the surgical technique, multifocal IOL power selection, ocular comorbidities, 
and patient selection. Comorbidities such as dry eye, vitreomacular pathology, or 
implant decentration may be tolerated in patients after a monofocal IOL implanta-
tion. However, these are much less tolerated by the multifocal IOL patients [83, 84].
Presbyopia-correcting intraocular lenses should provide post-op emmetropia 
for the best visual outcome, as small amounts of residual refractive errors can limit 
visual performance and jeopardize the result [85].
3.2.1 Preoperative examination and indications for refractive lens exchange
In evaluating the highly myopic patient, several aspects apart from the routine 
cataract/refractive surgery assessment should be noted. A detailed past ocular history 
is important, as previous refractive surgery or phakic intraocular lens implants or 
retinal problems (e.g., vitrectomy for previous retinal detachment) will affect lens 
formula choices and their final prognosis. Preoperative assessment should also 
include a detailed clinical examination of their lens status (e.g., cataract density and 
any zonular weakness) and refraction status of both eyes, as well as a dilated exami-
nation of the fovea and periphery for any retina disorder (e.g., myopic choroidal neo-
vascular membrane, macular schisis, retinal tears, or detachment). Other issues for 
discussion include the potential use of toric or multifocal IOLs. Ideally, a larger haptic 
platform toric lens should be used in high myopes to reduce the risk of postoperative 
lens rotation, as the capsular bag is often large and floppy. In some cases, the use of a 
capsular tension ring to stretch the capsular bag may be required to prevent rotations. 
Multifocal IOLs should only be used in an eye with no retinal disorder [86].
Inclusion criteria are more than 40 years of age with myopia not amenable to 
conventional laser refractive surgery (e.g., high refractive error, corneal irregulari-
ties, thin cornea) or phakic IOLS (e.g., shallow anterior chamber, poor endothelial 
cell count, early cataract changes), presbyopic myopic patients who want reason-
able independence from glasses for both distance, and near-vision, myopic patients 
with early lens changes who desire refractive correction [80, 86]. For multifocal IOL 
it is important to rule out any irregularities of iris or pupil function, evolving retinal 
pathology, absence of uveitis, or any kind of ocular inflammation.
Figure 6. 
Postoperative uncorrected distance visual acuity and patient satisfaction after RLE with implantation of 
multifocal IOLs.
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3.2.2 Limitations and possible complications of refractive lens exchange
The commonest disadvantage is the loss of accommodation with the need for 
near-vision glasses in the cases of monofocal IOL and the inherent risk associated 
with intraocular surgery, especially in high myopes [80]. The risk for endophthal-
mitis in general cataract surgery with implantation of a posterior chamber IOL is 
0.1–0.7% with an optimal antiseptic perioperative treatment regimen [87]. Lens 
surgery is significantly more challenging in a highly myopic eye for several reasons. 
The issues that we take for granted in an eye of normal length (22–25 mm) such as 
the accuracy of axial length measurements and the choice of lens formula become 
a significant issue in the highly myopic eye as the predicted refractive outcomes 
are not achieved consistently. Axial length measurement error has been largely 
overcome by the use of optical interferometry. Despite this, consistent hyperopic 
errors are still reported. Improved predictive results are obtained with the Barrett 
Universal II (software constants), Haigis (ULIB), SRK/T, Holladay 2 (software con-
stants), and Olsen (software constants) formulas in eyes with axial lengths greater 
than 26.0 mm and IOL powers greater than 6.0 D. In the eyes with axial lengths 
greater than 26.0 mm and IOL less than 6.00 D, the Barrett Universal II formula 
(software constants) and the Haigis (axial length adjusted) and Holladay 1 formulas 
(axial length adjusted) should be used [88, 89].
Intraoperatively, a highly myopic eye is surgically more challenging as the 
anterior chamber is deeper, with a floppy and large capsular bag and occasionally 
zonular weakness [90]. The anterior chamber is often unstable, and it is even less 
stable in a previously vitrectomized high myopic patient. There is also a concern 
that with elongated axial lengths, there is a higher risk of bag instability that can 
cause impaired vision, and the more complicated the IOL design is, the more 
sensitive the IOL is to final centration. A study by Soda et al. found that in uncom-
plicated cataract surgery with an IOL in the bag, the maximum decentration can be 
0.3 mm for a satisfying result [91]. In addition, it is reported that myopic patients 
may exhibit worse results with more reported subjective symptoms and measur-
able aberrations like coma and glare in mesopic and scotopic lighting conditions 
compared to non-myopic controls, after multifocal IOL implantation with approxi-
mately the same amount of decentration [91]. RLE may increase the risk for retinal 
detachment and is generally not considered in myopic pre-presbyopic patients who 
can still accommodate.
The incidence of retinal detachment is especially high among younger age 
groups (<50 years) and in the eyes with long axial length > 26 mm. The reported 
incidence of retinal detachment after RLE ranges from 2 to 8%. Meticulous sur-
gery with minimal intraoperative vitreous disturbance and a regular follow-up 
postoperatively until the occurrence of posterior vitreous detachment can reduce 
the risk of retinal detachment further. With the higher risk of retinal detachment 
in younger patients, it is prudent to defer RLE in patients younger than 40 years if 
possible [92].
Other possible causes of unfavorable visual outcome after uncomplicated 
phacoemulsification are cystoid macular edema (CME) and choroidal neovascular 
membrane (CNVM). Overall incidence of subclinical CME diagnosed with optical 
coherence tomography (OCT) is 5%, and incidence of clinical CME is 3%; however, 
high myopia does not increase the risk of CME [93]. Reported incidence of CNVM 
after RLE for myopia is 12.5% [94]; however, whether this was related to the higher 
degree of myopia with preexisting lacquer crack that was missed or due to some 
inflammatory mediators and free radicals released after surgery cannot be conclu-
sively proved. Because the reported incidence of CNVM after uncomplicated phaco-
emulsification is not high, we assume that it is secondary to the degree of myopia, 
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and it is prudent to perform OCT preoperatively in all RLE patients, especially those 
with more than 10 D of myopia. The presence of a myopic CNVM in the fellow eye is 
also considered as a risk factor for developing CNVM in the operated eye [80, 94].
4. Conclusions
Surgical treatment of myopia is a viable, safe, efficient, and predictable method 
for treating patients with myopia. There are several options of surgical treatment; 
we as doctors must always use our best judgment and available data to make sure we 
recommend the best method for each patient and their respective needs while tak-
ing into account any possible risk and contraindications. Among elective procedures 
in medicine, myopia treatment is one of the most commonly performed surgeries 
because of the positive effect it brings the patients’ quality of life.
Author details
Maja Bohac1,2*, Maja Pauk Gulic1,2, Alma Biscevic1,2 and Ivan Gabric1,2
1 Specialty Eye Hospital Svjetlost, Zagreb, Croatia
2 School of Medicine, University of Rijeka, Croatia
*Address all correspondence to: maja.bohac@svjetlost.hr
14
Intraocular Lens
References
[1] Fan DSP, Rao SK, Cheung EYY,  
Islam M, Chew S, Lam DSC. 
Astigmatism in Chinese preschool 
children: Prevalence, change, and effect 
on refractive development. The British 
Journal of Ophthalmology. 2004;88: 
938-941. DOI: 10.1136/bjo.2003.030338
[2] Dolgin E. The myopia boom. Nature. 
2015;519:276-278. DOI: 10.1038/519276a
[3] Holden BA, Fricke TR, Wilson DA, Jong 
M, Naidoo KS, Sankaridurg P, et al. Global 
prevalence of myopia and high myopia 
and temporal trends from 2000 through 
2050. Ophthalmology. 2016;123:1036-1042. 
DOI: 10.1016/j.ophtha.2016.01.006
[4] Reinstein DZ, Archer TJ, Gobbe M.  
The history of LASIK. Journal of 
Refractive Surgery. 2012;28:291-298. 
DOI: 10.3928/1081597X-20120229-01
[5] Ehlers N, Hjortdal JO. Excimer laser 
refractive keratectomy for high myopia. 
6-month follow-up of patients treated 
bilaterally. Acta Ophthalmologica. 
1992;70:578-586
[6] Rosman M, Alió JL, Ortiz D, Perez-
Santonja JJ. Comparison of LASIK and 
photorefractive keratectomy for myopia 
from −10.00 to −18.00 diopters 10 
years after surgery. Journal of Refractive 
Surgery. 2010;26:168-176. DOI: 
10.3928/1081597X-20100224-02
[7] Sia RK, Coe CD, Edwards JD, 
Ryan DS, Bower KS. Visual outcomes 
after Epi-LASIK and PRK for low 
and moderate myopia. Journal of 
Refractive Surgery. 2012;28:65-71. DOI: 
10.3928/1081597X-20111004-01
[8] Ambrósio R, Wilson S. LASIK 
vs LASEK vs PRK: Advantages 
and indications. Seminars in 
Ophthalmology. 2003;18:2-10
[9] Ghadhfan F, Al-Rajhi A, Wagoner MD.  
Laser in situ keratomileusis versus 
surface ablation: Visual outcomes and 
complications. Journal of Cataract and 
Refractive Surgery. 2007;33:2041-2048. 
DOI: 10.1016/j.jcrs.2007.07.026
[10] Hofmeister EM, Bishop FM,  
Kaupp SE, Schallhorn SC. Randomized 
dose-response analysis of mitomycin-C 
to prevent haze after photorefractive 
keratectomy for high myopia. Journal 
of Cataract and Refractive Surgery. 
2013;39:1358-1365. DOI: 10.1016/j.
jcrs.2013.03.029
[11] Gimbel HV, DeBroff BM, Beldavs RA, 
van Westenbrugge JA, Ferensowicz M.  
Comparison of laser and manual 
removal of corneal epithelium for 
photorefractive keratectomy. Journal of 
Refractive Surgery. 1995;11:36-41
[12] von Jagow B, Kohnen T. Corneal 
architecture of femtosecond laser and 
microkeratome flaps imaged by anterior 
segment optical coherence tomography. 
Journal of Cataract and Refractive 
Surgery. 2009;35:35-41. DOI: 10.1016/j.
jcrs.2008.09.013
[13] Reinstein DZ, Archer TJ, Randleman 
JB. Mathematical model to compare 
the relative tensile strength of the 
cornea after PRK, LASIK, and small 
incision lenticule extraction. Journal of 
Refractive Surgery. 2013;29:454-460. 
DOI: 10.3928/1081597X-20130617-03
[14] Guerin MB, Darcy F, O’Connor J, 
O’Keeffe M. Excimer laser photorefractive 
keratectomy for low to moderate myopia 
using a 5.0 mm treatment zone and no 
transitional zone: 16-year follow-up. 
Journal of Cataract and Refractive Surgery. 
2012;38(7):1246-1250. DOI: 10.1016/j.
jcrs.2012.03.027
[15] Sekundo W, Kunert KS, Blum M.  
Small incision corneal refractive surgery 
using the small incision lenticule 
extraction (SMILE) procedure for 
the correction of myopia and myopic 
15
Surgical Correction of Myopia
DOI: http://dx.doi.org/10.5772/intechopen.85644
astigmatism: Results of a 6 month 
prospective study. The British Journal of 
Ophthalmology. 2011;95:335-339. DOI: 
10.1136/bjo.2009.174284
[16] Wu D, Wang Y, Zhang L, Wei S, 
Tang X. Corneal biomechanical effects: 
Small-incision lenticule extraction versus 
femtosecond laser-assisted laser in situ 
keratomileusis. Journal of Cataract and 
Refractive Surgery. 2014;40:954-962. 
DOI: 10.1016/j.jcrs.2013.07.056
[17] Thompson V, Gordon M. Use 
of the excimer laser in refractive 
surgery. Seminars in Ophthalmology. 
1994;9:91-96
[18] Carr J, Hersh P, Tsubota K. Patient 
evaluation for refractive surgery. In: 
Azar D, editor. Refractive Surgery. 
2nd ed. Philadelphia: Elsevier Inc.; 
2007. pp. 81-88. DOI: 10.1016/
B978-0-323-03599-6.50068-7
[19] Morse JS, Schallhorn SC, Hettinger K, 
Tanzer D. Role of depressive symptoms 
in patient satisfaction with visual 
quality after laser in situ keratomileusis. 
Journal of Cataract and Refractive 
Surgery. 2009;35:341-346. DOI: 
10.1016/j.jcrs.2008.10.046
[20] Nourouzi H, Rajavi J, Okhovatpour 
MA. Time to resolution of corneal 
edema after long-term contact lens wear. 
American Journal of Ophthalmology. 
2006;142:671-673. DOI: 10.1016/j.
ajo.2006.04.061
[21] Chuck RS, Jacobs DS, Lee JK, 
Afshari NA, Vitale S, Shen TT, et al. 
Refractive errors and refractive 
surgery preferred practice pattern®. 
Ophthalmology. 2018;125:P1-P104. DOI: 
10.1016/j.ophtha.2017.10.003
[22] Cua IY, Pepose JS. Late corneal 
scarring after photorefractive 
keratectomy concurrent with 
development of systemic lupus 
erythematosus. Journal of Refractive 
Surgery. 2002;18:750-752
[23] Simpson RG, Moshirfar M, Edmonds 
JN, Christiansen SM, Behunin N.  
Laser in situ keratomileusis in patients 
with collagen vascular disease: A 
review of the literature. Clinical 
Ophthalmology. 2012;6:1827-1837. DOI: 
10.2147/OPTH.S36690
[24] Fraunfelder FW, Rich LF. Laser-
assisted in situ keratomileusis 
complications in diabetes mellitus. 
Cornea. 2002;21:246-248
[25] Sharma S, Rekha W, Sharma T,  
Downey G. Refractive issues in 
pregnancy. The Australian & New 
Zealand Journal of Obstetrics & 
Gynaecology. 2006;46:186-188. DOI: 
10.1111/j.1479-828X.2006.00569.x
[26] Seiler T, Koufala K, Richter G.  
Iatrogenic keratectasia after laser in situ 
keratomileusis. Journal of Refractive 
Surgery. 1998;14:312-317
[27] Hodge C, Lawless M, Sutton G.  
Keratectasia following LASIK in a 
patient with uncomplicated PRK in 
the fellow eye. Journal of Cataract and 
Refractive Surgery. 2011;37:603-607. 
DOI: 10.1016/j.jcrs.2010.12.036
[28] Randleman JB, Woodward M,  
Lynn MJ, Stulting RD. Risk assessment 
for ectasia after corneal refractive 
surgery. Ophthalmology. 2008;115:37-50. 
DOI: 10.1016/j.ophtha.2007.03.073
[29] Santhiago MR, Smadja D,  
Wilson SE, Krueger RR, Monteiro 
MLR, Randleman JB. Role of 
percent tissue altered on ectasia 
after LASIK in eyes with suspicious 
topography. Journal of Refractive 
Surgery. 2015;31:258-265. DOI: 
10.3928/1081597X-20150319-05
[30] Cobo-Soriano R, Beltrán J,  
Baviera J. LASIK outcomes in 
patients with underlying systemic 
contraindications: A preliminary study. 
Ophthalmology. 2006;113. DOI: 1118.
e1-8. doi:10.1016/j.ophtha.2006.02.023
Intraocular Lens
16
[31] Arora T, Sharma N, Arora S,  
Titiyal JS. Fulminant herpetic keratouveitis 
with flap necrosis following laser in situ 
keratomileusis: Case report and review 
of literature. Journal of Cataract and 
Refractive Surgery. 2014;40:2152-2156. 
DOI: 10.1016/j.jcrs.2014.09.018
[32] Ahn H, Kim J-K, Kim CK, Han GH, 
Seo KY, Kim EK, et al. Comparison 
of laser in situ keratomileusis flaps 
created by 3 femtosecond lasers and a 
microkeratome. Journal of Cataract and 
Refractive Surgery. 2011;37:349-357. 
DOI: 10.1016/j.jcrs.2010.08.042
[33] Farah S, Ghanem R, Azar D. LASIK 
complications and their management. 
In: Azar D, editor. Refractive Surgery. 
2nd ed. Philadelphia: Elsevier Inc.; 2007. 
pp. 195-221
[34] Rush SW, Cofoid P, Rush RB.  
Incidence and outcomes of anterior 
chamber gas bubble during 
femtosecond flap creation for laser-
assisted in situ keratomileusis. Journal 
of Ophthalmology. 2015;2015:542127. 
DOI: 10.1155/2015/542127
[35] Stonecipher KG, Dishler JG,  
Ignacio TS, Binder PS. Transient light 
sensitivity after femtosecond laser 
flap creation: Clinical findings and 
management. Journal of Cataract and 
Refractive Surgery. 2006;32:91-94. DOI: 
10.1016/j.jcrs.2005.11.015
[36] Carpel EF, Carlson KH, Shannon 
S. Folds and striae in laser in situ 
keratomileusis flaps. Journal of 
Refractive Surgery. 1999;15:687-690
[37] Samuel MA, Kaufman SC,  
Ahee JA, Wee C, Bogorad D. Diffuse 
lamellar keratitis associated with 
carboxymethylcellulose sodium 1% 
after laser in situ keratomileusis. Journal 
of Cataract and Refractive Surgery. 
2002;28:1409-1411
[38] Kaufman SC. Post-LASIK interface 
keratitis, Sands of the Sahara syndrome, 
and microkeratome blades. Journal 
of Cataract and Refractive Surgery. 
1999;25:603-604
[39] Linebarger EJ, Hardten DR, 
Lindstrom RL. Diffuse lamellar 
keratitis: Diagnosis and management. 
Journal of Cataract and Refractive 
Surgery. 2000;26:1072-1077
[40] Sonmez B, Maloney RK. Central 
toxic keratopathy: Description of a 
syndrome in laser refractive surgery. 
American Journal of Ophthalmology. 
2007;143:420-427.e2. DOI: 10.1016/J.
AJO.2006.11.019
[41] Miyai T, Yonemura T, Nejima R,  
Otani S, Miyata K, Amano S. 
Interlamellar flap edema due to steroid-
induced ocular hypertension after laser 
in situ keratomileusis. Japanese Journal 
of Ophthalmology. 2007. DOI: 10.1007/
s10384-006-0441-y
[42] Llovet F, de Rojas V, Interlandi E,  
Martín C, Cobo-Soriano R, Ortega-
Usobiaga J, et al. Infectious keratitis 
in 204 586 LASIK procedures. 
Ophthalmology. 2010;117:232.
e1-4-238.e1-4. DOI: 10.1016/j.
ophtha.2009.07.011
[43] Caster AI, Friess DW, Schwendeman 
FJ. Incidence of epithelial ingrowth in 
primary and retreatment laser in situ 
keratomileusis. Journal of Cataract and 
Refractive Surgery. 2010;36:97-101. 
DOI: 10.1016/j.jcrs.2009.07.039
[44] Albietz JM, Lenton LM,  
McLennan SG, McLennan SG. Chronic 
dry eye and regression after laser in 
situ keratomileusis for myopia. Journal 
of Cataract and Refractive Surgery. 
2004;30:675-684. DOI: 10.1016/j.
jcrs.2003.07.003
[45] Myung D, Schallhorn S, 
Manche EE. Pupil size and LASIK: 
A review. Journal of Refractive 
Surgery. 2013;29:734-741. DOI: 
10.3928/1081597X-20131021-02
17
Surgical Correction of Myopia
DOI: http://dx.doi.org/10.5772/intechopen.85644
[46] Alió JL, Muftuoglu O, Ortiz D, 
Artola A, Pérez-Santonja JJ, de Luna GC, 
et al. Ten-year follow-up of 
photorefractive keratectomy for myopia 
of more than −6 diopters. American 
Journal of Ophthalmology. 2008;145: 
37-45. DOI: 10.1016/j.ajo.2007.09.009
[47] Alió JL, Soria F, Abbouda A, Peña-
García P. Laser in situ keratomileusis for 
−6.00 to −18.00 diopters of myopia and 
up to −5.00 diopters of astigmatism: 
15-year follow-up. Journal of Cataract 
and Refractive Surgery. 2015;41:33-40. 
DOI: 10.1016/j.jcrs.2014.08.029
[48] Santhiago MR, Giacomin NT, 
Smadja D, Bechara SJ. Ectasia risk 
factors in refractive surgery. Clinical 
Ophthalmology. 2016;10:713-720. DOI: 
10.2147/OPTH.S51313
[49] Giri P, Azar DT. Risk profiles of 
ectasia after keratorefractive surgery. 
Current Opinion in Ophthalmology. 
2017;28:337-342. DOI: 10.1097/
ICU.0000000000000383
[50] Chan C, Lawless M, Sutton G, 
Versace P, Hodge C. Small incision 
lenticule extraction (SMILE) in 2015. 
Clinical and Experimental Optometry. 
2016;99:204-212. DOI: 10.1111/
cxo.12380
[51] Ivarsen A, Hjortdal JØ. Topography-
guided photorefractive keratectomy 
for irregular astigmatism after small 
incision lenticule extraction. Journal of 
Refractive Surgery. 2014;30:429-432. 
DOI: 10.3928/1081597X-20140508-02
[52] Huang D, Schallhorn SC, Sugar A,  
Farjo AA, Majmudar PA, Trattler 
WB, et al. Phakic intraocular lens 
implantation for the correction of 
myopiaa report by the American 
Academy of Ophthalmology. 
Ophthalmology. 2009;116:2244-2258. 
DOI: 10.1016/j.ophtha.2009.08.018
[53] Applegate RA, Howland HC.  
Refractive surgery, optical aberrations, 
and visual performance. Journal of 
Refractive Surgery. 1997;13:295-299
[54] Igarashi A, Shimizu K, Kamiya K.  
Eight-year follow-up of posterior 
chamber phakic intraocular lens 
implantation for moderate to high 
myopia. American Journal of 
Ophthalmology. 2014;157:532-539.e1. 
DOI: 10.1016/j.ajo.2013.11.006
[55] Ghanem R, Azer D. Phakic 
intraocular lenses. In: Yanoff M, 
Augsburger JJ, editors. Ophthalmology. 
Edinburgh: Mosby, Elsevier; 2009, p. 186
[56] Pineda-Fernández A,  
Jaramillo J, Vargas J, Jaramillo M, 
Jaramillo J, Galíndez A. Phakic 
posterior chamber intraocular lens for 
high myopia. Journal of Cataract and 
Refractive Surgery. 2004;30:2277-2283. 
DOI: 10.1016/j.jcrs.2004.03.035
[57] Javitt JC, Tielsch JM, Canner JK, 
Kolb MM, Sommer A, Steinberg EP.  
National outcomes of cataract 
extraction. Increased risk of retinal 
complications associated with Nd:YAG 
laser capsulotomy. The Cataract 
Patient Outcomes Research Team. 
Ophthalmology. 1992;99:1487-1497; 
discussion 1497-8
[58] Van Der Heijde GL. Some optical 
aspects of implantation of an IOL 
in a myopic eye. European Journal 
of Implant Refractive Surgery. 
1989;1:245-248. DOI: 10.1016/
S0955-3681(89)80082-6
[59] Sanders DR, Vukich JA, Doney K, 
Gaston M, Implantable Contact Lens 
in Treatment of Myopia Study Group. 
U.S. Food and Drug Administration 
clinical trial of the Implantable Contact 
Lens for moderate to high myopia. 
Ophthalmology. 2003;110:255-266
[60] Goukon H, Kamiya K, Shimizu K,  
Igarashi A. Comparison of corneal 
endothelial cell density and morphology 
after posterior chamber phakic 
Intraocular Lens
18
intraocular lens implantation with 
and without a central hole. The 
British Journal of Ophthalmology. 
2017;101:1461-1465. DOI: 10.1136/
bjophthalmol-2016-309363
[61] Kohnen T, Kook D, Morral M,  
Güell JL. Phakic intraocular lenses: Part 
2: Results and complications. Journal 
of Cataract and Refractive Surgery. 
2010;36:2168-2194. DOI: 10.1016/j.
jcrs.2010.10.007
[62] Alió JL, Mulet ME, Shalaby AMM.  
Artisan phakic iris claw intraocular 
lens for high primary and secondary 
hyperopia. Journal of Refractive 
Surgery. 2002;18:697-707
[63] Menezo JL, Aviño JA, Cisneros A, 
Rodriguez-Salvador V, Martinez-Costa R.  
Iris claw phakic intraocular lens for high 
myopia. Journal of Refractive Surgery. 
1997;13:545-555
[64] Coullet J, Guëll J-L, Fournié P, 
Grandjean H, Gaytan J, Arné J-L, 
et al. Iris-supported phakic lenses 
(rigid vs foldable version) for 
treating moderately high myopia: 
Randomized paired eye comparison. 
American Journal of Ophthalmology. 
2006;142:909-916. DOI: 10.1016/j.
ajo.2006.07.021
[65] Bourne WM, Nelson LR, Hodge 
DO. Central corneal endothelial 
cell changes over a ten-year period. 
Investigative Ophthalmology and Visual 
Science. 1997;38:779-782
[66] Chebli S, Rabilloud M, Burillon C,  
Kocaba V. Corneal endothelial tolerance 
after iris-fixated phakic intraocular 
lens implantation: A model to predict 
endothelial cell survival. Cornea. 
2018;37:591-595. DOI: 10.1097/
ICO.0000000000001527
[67] Moya T, Javaloy J, Montés-Micó R, 
Beltrán J, Muñoz G, Montalbán R.  
Implantable collamer lens for 
myopia: Assessment 12 years after 
implantation. Journal of Refractive 
Surgery. 2015;31:548-556. DOI: 
10.3928/1081597X-20150727-05
[68] Stulting RD, John ME, Maloney RK, 
Assil KK, Arrowsmith PN, Thompson 
VM, et al. Three-year results of Artisan/
Verisyse phakic intraocular lens 
implantation. Results of the United 
States Food And Drug Administration 
clinical trial. Ophthalmology. 
2008;115:464-472, e1. DOI: 10.1016/j.
ophtha.2007.08.039
[69] Hoyos JE, Dementiev DD, Cigales M,  
Hoyos-Chacón J, Hoffer KJ. Phakic 
refractive lens experience in Spain. 
Journal of Cataract and Refractive 
Surgery. 2002;28:1939-1946
[70] García-Feijoó J, Alfaro IJ, Cuiña-
Sardiña R, Méndez-Hernandez C, Del 
Castillo JMB, García-Sánchez J.  
Ultrasound biomicroscopy examination 
of posterior chamber phakic intraocular 
lens position. Ophthalmology. 
2003;110:163-172
[71] Maloney RK, Nguyen LH, John ME.  
Artisan phakic intraocular lens 
for myopia: Short-term results of 
a prospective, multicenter study. 
Ophthalmology. 2002;109:1631-1641
[72] Chen L-J, Chang Y-J, Kuo JC, 
Rajagopal R, Azar DT. Metaanalysis 
of cataract development after phakic 
intraocular lens surgery. Journal of 
Cataract and Refractive Surgery. 
2008;34:1181-1200. DOI: 10.1016/j.
jcrs.2008.03.029
[73] Menezo JL, Peris-Martínez C, 
Cisneros A, Martínez-Costa R. Posterior 
chamber phakic intraocular lenses to 
correct high myopia: A comparative 
study between Staar and Adatomed 
models. Journal of Refractive Surgery. 
2001;17:32-42
[74] Gonvers M, Bornet C, Othenin-
Girard P. Implantable contact lens for 
moderate to high myopia: Relationship 
19
Surgical Correction of Myopia
DOI: http://dx.doi.org/10.5772/intechopen.85644
of vaulting to cataract formation. 
Journal of Cataract Refractive Surgery. 
2003;29:918-924
[75] Sánchez-Galeana CA, Smith RJ, 
Sanders DR, Rodríguez FX, Litwak S, 
Montes M, et al. Lens opacities after 
posterior chamber phakic intraocular 
lens implantation. Ophthalmology. 
2003;110:781-785
[76] Lackner B, Pieh S, Schmidinger G, 
Hanselmayer G, Dejaco-Ruhswurm I,  
Funovics MA, et al. Outcome 
after treatment of ametropia 
with implantable contact lenses. 
Ophthalmology. 2003;110:2153-2161. 
DOI: 10.1016/S0161-6420(03)00830-3
[77] Güell JL, Morral M, Gris O, Gaytan J, 
Sisquella M, Manero F. Five-year 
follow-up of 399 phakic Artisan-Verisyse 
implantation for myopia, hyperopia, 
and/or astigmatism. Ophthalmology. 
2008;115:1002-1012. DOI: 10.1016/j.
ophtha.2007.08.022
[78] Chung JK, Lee SJ. Streptococcus 
mitis/oralis endophthalmitis 
management without phakic intraocular 
lens removal in patient with iris-fixated 
phakic intraocular lens implantation. 
BMC Ophthalmology. 2014;14:92. DOI: 
10.1186/1471-2415-14-92
[79] Couto C, Rossetti S, Schlaen A,  
Hurtado E, D’Alessandro L, 
Goldstein DA. Chronic postoperative 
Mycobacterium gordonae 
endophthalmitis in a patient with phakic 
intraocular lens. Ocular Immunology 
and Inflammation. 2013;21:491-494. 
DOI: 10.3109/09273948.2013.824104
[80] Srinivasan B, Leung HY, Cao H,  
Liu S, Chen L, Fan AH. Modern 
phacoemulsification and intraocular 
lens implantation (refractive lens 
exchange) is safe and effective 
in treating high myopia. Asia-
Pacific Journal of Ophthalmology. 
2016;5:438-444. DOI: 10.1097/
APO.0000000000000241
[81] Lundström M, Manning S, Barry P,  
Stenevi U, Henry Y, Rosen P. The European 
registry of quality outcomes for cataract 
and refractive surgery (EUREQUO): 
A database study of trends in volumes, 
surgical techniques and outcomes of 
refractive surgery. Eye Vision. 2015;2:8. 
DOI: 10.1186/s40662-015-0019-1
[82] Alio JL, Grzybowski A, El Aswad A,  
Romaniuk D. Refractive lens exchange. 
Survival Ophthalmology. Nov-Dec 
2014;59(6):579-98. DOI: 10.1016/j.
survophthal.2014.04.004. Epub 2014 
May 9
[83] Braga-Mele R, Chang D, Dewey S, 
Foster G, Henderson BA, Hill W, et al. 
Multifocal intraocular lenses: Relative 
indications and contraindications for 
implantation. Journal of Cataract and 
Refractive Surgery. 2014;40:313-322. 
DOI: 10.1016/j.jcrs.2013.12.011
[84] Kamiya K, Hayashi K, Shimizu K, 
Negishi K, Sato M, Bissen-Miyajima H,  
et al. Multifocal intraocular lens 
explantation: A case series of 50 eyes. 
American Journal of Ophthalmology. 
2014;158:215-220.e1. DOI: 10.1016/j.
ajo.2014.04.010
[85] McNeely RN, Pazo E, Millar Z,  
Richoz O, Nesbit A, Moore TCB, et al. 
Threshold limit of postoperative 
astigmatism for patient satisfaction after 
refractive lens exchange and multifocal 
intraocular lens implantation. Journal 
of Cataract and Refractive Surgery. 
2016;42:1126-1134. DOI: 10.1016/j.
jcrs.2016.05.007
[86] Chong EW, Mehta JS. High myopia 
and cataract surgery. Current Opinion 
in Ophthalmology. 2016;27:45-50. DOI: 
10.1097/ICU.0000000000000217
[87] Results of the Endophthalmitis 
Vitrectomy Study. A randomized 
trial of immediate vitrectomy and 
of intravenous antibiotics for the 
treatment of postoperative bacterial 
endophthalmitis. Endophthalmitis 
Intraocular Lens
20
Vitrectomy Study Group. Archives of 
Ophthalmology. 1995;113:1479-1496.
[88] Haigis W. Intraocular lens 
calculation in extreme myopia. Journal 
of Cataract and Refractive Surgery. 
2009;35:906-911. DOI: 10.1016/j.
jcrs.2008.12.035
[89] Yokoi T, Moriyama M, Hayashi K, 
Shimada N, Ohno-Matsui K. Evaluation 
of refractive error after cataract surgery 
in highly myopic eyes. International 
Ophthalmology. 2013;33:343-348. DOI: 
10.1007/s10792-012-9690-6
[90] Fernández-Buenaga R, Alio JL, 
Pérez-Ardoy AL, Larrosa-Quesada A, 
Pinilla-Cortés L, Barraquer R, et al. Late 
in-the-bag intraocular lens dislocation 
requiring explantation: Risk factors and 
outcomes. Eye. 2013;27:795-801; quiz 
802. DOI: 10.1038/eye.2013.95
[91] Soda M, Yaguchi S. Effect of 
decentration on the optical performance 
in multifocal intraocular lenses. 
Ophthalmologica. 2012;227:197-204. 
DOI: 10.1159/000333820
[92] Alio JL, Ruiz-Moreno JM,  
Shabayek MH, Lugo FL,  
Abd El Rahman AM, Alicante D.  
The risk of retinal detachment in high 
myopia after small incision coaxial 
phacoemulsification. American Journal 
of Ophthalmology. 2007;144:93-98. 
DOI: 10.1016/j.ajo.2007.03.043
[93] Vukicevic M, Gin T, Al-Qureshi S.  
Prevalence of optical coherence 
tomography-diagnosed postoperative 
cystoid macular oedema in 
patients following uncomplicated 
phaco-emulsification cataract 
surgery. Clinical & Experimental 
Ophthalmology. 2012;40:282-287. DOI: 
10.1111/j.1442-9071.2011.02638.x
[94] Hayashi K, Ohno-Matsui K, 
Futagami S, Ohno S, Tokoro T,  
Mochizuki M. Choroidal 
neovascularization in highly myopic eyes 
after cataract surgery. Japanese Journal 
of Ophthalmology. 2006;50:345-348. 
DOI: 10.1007/s10384-006-0335-z
